Exploring active ingredients and function mechanisms of Ephedra-bitter almond for prevention and treatment of Corona virus disease 2019 (COVID-19) based on network pharmacology

Abstract Background COVID-19 has caused a global pandemic, and there is no wonder drug for epidemic control at present. However, many clinical practices have shown that traditional Chinese medicine has played an important role in treating the outbreak. Among them, ephedra-bitter almond is a common c...

Full description

Bibliographic Details
Main Authors: Kai Gao, Yan-Ping Song, Anna Song
Format: Article
Language:English
Published: BMC 2020-11-01
Series:BioData Mining
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13040-020-00229-4
_version_ 1828813583784345600
author Kai Gao
Yan-Ping Song
Anna Song
author_facet Kai Gao
Yan-Ping Song
Anna Song
author_sort Kai Gao
collection DOAJ
description Abstract Background COVID-19 has caused a global pandemic, and there is no wonder drug for epidemic control at present. However, many clinical practices have shown that traditional Chinese medicine has played an important role in treating the outbreak. Among them, ephedra-bitter almond is a common couplet medicine in anti-COVID-19 prescriptions. This study aims to conduct an exploration of key components and mechanisms of ephedra-bitter almond anti-COVID-19 based on network pharmacology. Material and methods We collected and screened potential active components of ephedra-bitter almond based on the TCMSP Database, and we predicted targets of the components. Meanwhile, we collected relevant targets of COVID-19 through the GeneCards and CTD databases. Then, the potential targets of ephedra-bitter almond against COVID-19 were screened out. The key components, targets, biological processes, and pathways of ephedra-bitter almond anti-COVID-19 were predicted by constructing the relationship network of herb-component-target (H-C-T), protein-protein interaction (PPI), and functional enrichment. Finally, the key components and targets were docked by AutoDock Vina to explore their binding mode. Results Ephedra-bitter almond played an overall regulatory role in anti-COVID-19 via the patterns of multi-component-target-pathway. In addition, some key components of ephedra-bitter almond, such as β-sitosterol, estrone, and stigmasterol, had high binding activity to 3CL and ACE2 by molecular docking simulation, which provided new molecular structures for new drug development of COVID-19. Conclusion Ephedra-bitter almonds were used to prevent and treat COVID-19 through directly inhibiting the virus, regulating immune responses, and promoting body repair. However, this work is a prospective study based on data mining, and the findings need to be interpreted with caution.
first_indexed 2024-12-12T10:04:20Z
format Article
id doaj.art-6eba621cb37547c8a14c44addc2c0a5d
institution Directory Open Access Journal
issn 1756-0381
language English
last_indexed 2024-12-12T10:04:20Z
publishDate 2020-11-01
publisher BMC
record_format Article
series BioData Mining
spelling doaj.art-6eba621cb37547c8a14c44addc2c0a5d2022-12-22T00:27:56ZengBMCBioData Mining1756-03812020-11-0113112010.1186/s13040-020-00229-4Exploring active ingredients and function mechanisms of Ephedra-bitter almond for prevention and treatment of Corona virus disease 2019 (COVID-19) based on network pharmacologyKai Gao0Yan-Ping Song1Anna Song2Pharmacy College, Shaanxi University of Chinese MedicineShaanxi Academy of Traditional Chinese MedicineMichigan State UniversityAbstract Background COVID-19 has caused a global pandemic, and there is no wonder drug for epidemic control at present. However, many clinical practices have shown that traditional Chinese medicine has played an important role in treating the outbreak. Among them, ephedra-bitter almond is a common couplet medicine in anti-COVID-19 prescriptions. This study aims to conduct an exploration of key components and mechanisms of ephedra-bitter almond anti-COVID-19 based on network pharmacology. Material and methods We collected and screened potential active components of ephedra-bitter almond based on the TCMSP Database, and we predicted targets of the components. Meanwhile, we collected relevant targets of COVID-19 through the GeneCards and CTD databases. Then, the potential targets of ephedra-bitter almond against COVID-19 were screened out. The key components, targets, biological processes, and pathways of ephedra-bitter almond anti-COVID-19 were predicted by constructing the relationship network of herb-component-target (H-C-T), protein-protein interaction (PPI), and functional enrichment. Finally, the key components and targets were docked by AutoDock Vina to explore their binding mode. Results Ephedra-bitter almond played an overall regulatory role in anti-COVID-19 via the patterns of multi-component-target-pathway. In addition, some key components of ephedra-bitter almond, such as β-sitosterol, estrone, and stigmasterol, had high binding activity to 3CL and ACE2 by molecular docking simulation, which provided new molecular structures for new drug development of COVID-19. Conclusion Ephedra-bitter almonds were used to prevent and treat COVID-19 through directly inhibiting the virus, regulating immune responses, and promoting body repair. However, this work is a prospective study based on data mining, and the findings need to be interpreted with caution.http://link.springer.com/article/10.1186/s13040-020-00229-4COVID-19Ephedra-bitter almondMolecular docking simulationTraditional Chinese medicineMolecular mechanisms of pharmacological action
spellingShingle Kai Gao
Yan-Ping Song
Anna Song
Exploring active ingredients and function mechanisms of Ephedra-bitter almond for prevention and treatment of Corona virus disease 2019 (COVID-19) based on network pharmacology
BioData Mining
COVID-19
Ephedra-bitter almond
Molecular docking simulation
Traditional Chinese medicine
Molecular mechanisms of pharmacological action
title Exploring active ingredients and function mechanisms of Ephedra-bitter almond for prevention and treatment of Corona virus disease 2019 (COVID-19) based on network pharmacology
title_full Exploring active ingredients and function mechanisms of Ephedra-bitter almond for prevention and treatment of Corona virus disease 2019 (COVID-19) based on network pharmacology
title_fullStr Exploring active ingredients and function mechanisms of Ephedra-bitter almond for prevention and treatment of Corona virus disease 2019 (COVID-19) based on network pharmacology
title_full_unstemmed Exploring active ingredients and function mechanisms of Ephedra-bitter almond for prevention and treatment of Corona virus disease 2019 (COVID-19) based on network pharmacology
title_short Exploring active ingredients and function mechanisms of Ephedra-bitter almond for prevention and treatment of Corona virus disease 2019 (COVID-19) based on network pharmacology
title_sort exploring active ingredients and function mechanisms of ephedra bitter almond for prevention and treatment of corona virus disease 2019 covid 19 based on network pharmacology
topic COVID-19
Ephedra-bitter almond
Molecular docking simulation
Traditional Chinese medicine
Molecular mechanisms of pharmacological action
url http://link.springer.com/article/10.1186/s13040-020-00229-4
work_keys_str_mv AT kaigao exploringactiveingredientsandfunctionmechanismsofephedrabitteralmondforpreventionandtreatmentofcoronavirusdisease2019covid19basedonnetworkpharmacology
AT yanpingsong exploringactiveingredientsandfunctionmechanismsofephedrabitteralmondforpreventionandtreatmentofcoronavirusdisease2019covid19basedonnetworkpharmacology
AT annasong exploringactiveingredientsandfunctionmechanismsofephedrabitteralmondforpreventionandtreatmentofcoronavirusdisease2019covid19basedonnetworkpharmacology